Cholangiocarcinoma
(CCA), an aggressive malignancy arising from
the biliary epithelium, exhibits a high incidence in Thailand. CCA
usually lacks specific symptoms and is typically diagnosed in its
advanced stages, presenting significant treatment challenges. Current
CCA therapeutic options, including surgery, chemotherapy, and radiation,
have limited success rates and often cause side effects. Nature-derived
compounds hold promise for reducing undesirable adverse effects and
are an excellent source of anticancer drugs. Corosolic acid (CA),
a triterpenoid found in Lagerstroemia speciosa L. leaves, exhibits anticancer properties; however, the effectiveness
of CA against CCA and its molecular mechanisms remained unexplored.
Herein, the anti-CCA and apoptosis-inducing effects of CA were investigated
using various techniques, i.e., the MTT assay, flow
cytometry with FITC-labeled Annexin V (Annexin V-FITC) and propidium
iodide double staining, JC-1 staining, western blot analysis, caspase-3
activity assay, and molecular dynamics (MD) simulations. CA inhibited
the proliferation of KKU-213A and KKU-213B CCA cells and triggered
apoptosis through alterations in mitochondrial membrane potential
(ΔΨm), and increases in the Bax/Bcl-2 expression ratio,
cytochrome c release, and caspase-3 activity. As
indicated by MD simulations, CA has the potential to bind to Bcl-2
through hydrogen bonds between amino acid residues R146 and N143.
These findings underscore the potential of CA as a promising candidate
for treatment of CCA.